Treatment method

Details for Australian Patent Application No. 2010273254 (hide)

Owner Glaxo Wellcome Manufacturing Pte Ltd

Inventors McLaughlin, Megan M.; Wurzelmann, John Irving; Xu, Chun-Fang

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010273254

PCT Pub. Number WO2011/009016

Priority 61/226,113 16.07.09 US

Filing date 16 July 2010

Wipo publication date 20 January 2011

International Classifications

A01N 43/56 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/009016 Priority application(s): WO2011/009016

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010273259-Processes for the synthesis of (2S, 3aR, 7aS)-octahydro-1H-indole carboxylic acid as an intermediate for trandolapril

2010273253-(+) - morphinans as antagonists of Tolllike receptor 9 and therapeutic uses thereof